Showing results (271-280 of 419) with videos related to

Sort By:
Pageof 42
Xenotransplantation|July 17, 2015
In vitro exposure of pig neonatal isletlike cell clusters to human bloodSantosh Nagaraju, Suzanne Bertera, Takayuki Tanaka, et al.
Pancreas|September 28, 2006
Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responsesPleunie P M Rood, Rita Bottino, A N Balamurugan, et al.
Frontiers in Immunology|December 27, 2021
The Role of Interleukin-6 (IL-6) in the Systemic Inflammatory Response in Xenograft Recipients and in Pig Kidney Xenograft FailureGuoqiang Zhang, Hayato Iwase, Qi Li, et al.
Cellular Immunology|September 19, 2013
Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cellsJiang Li, Oleg Andreyev, Man Chen, et al.
Annals of Surgery|September 12, 2024
The Time Has Come: The Case for Initiating Pilot Clinical Trials of Pig Kidney XenotransplantationDavid K C Cooper, Leonardo V Riella, Tatsuo Kawai, et al.
Transplantation|February 29, 2024
Pediatric Cardiac Xenotransplantation: Recommendations for the Ethical Design of Clinical TrialsDaniel J Hurst, Luz Padilla, Anthony Merlocco, et al.
Xenotransplantation|October 3, 2009
Current status of xenotransplantation and prospects for clinical applicationRichard N Pierson, Anthony Dorling, David Ayares, et al.
Experimental Hematology|October 19, 2006
Primitive hematopoietic cell populations reside in the spleen: Studies in the pig, baboon, and humanFrank J M F Dor, Mario L Ramirez, Kalindi Parmar, et al.
Xenotransplantation|October 20, 2010
An in vitro model of pig liver xenotransplantation--pig complement is associated with reduced lysis of wild-type and genetically modified pig cellsHidetaka Hara, Nathalie Campanile, Hao-Chih Tai, et al.
Xenotransplantation|February 27, 2016
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trialDavid K C Cooper, Rita Bottino, Pierre Gianello, et al.
Pageof 42